These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Evaluation of anti-cocaine antibodies and a cocaine vaccine in a rat self-administration model. Kantak KM; Collins SL; Lipman EG; Bond J; Giovanoni K; Fox BS Psychopharmacology (Berl); 2000 Feb; 148(3):251-62. PubMed ID: 10755738 [TBL] [Abstract][Full Text] [Related]
13. Human therapeutic cocaine vaccine: safety and immunogenicity. Kosten TR; Rosen M; Bond J; Settles M; Roberts JS; Shields J; Jack L; Fox B Vaccine; 2002 Jan; 20(7-8):1196-204. PubMed ID: 11803082 [TBL] [Abstract][Full Text] [Related]
14. A potential vaccine for cocaine abuse prophylaxis. Bagasra O; Forman LJ; Howeedy A; Whittle P Immunopharmacology; 1992; 23(3):173-9. PubMed ID: 1500284 [TBL] [Abstract][Full Text] [Related]
17. Ethical issues in using a cocaine vaccine to treat and prevent cocaine abuse and dependence. Hall W; Carter L J Med Ethics; 2004 Aug; 30(4):337-40. PubMed ID: 15289512 [TBL] [Abstract][Full Text] [Related]
18. Suppression of psychoactive effects of cocaine by active immunization. Carrera MR; Ashley JA; Parsons LH; Wirsching P; Koob GF; Janda KD Nature; 1995 Dec; 378(6558):727-30. PubMed ID: 7501020 [TBL] [Abstract][Full Text] [Related]
19. Development of a therapeutic vaccine for the treatment of cocaine addiction. Fox BS Drug Alcohol Depend; 1997 Dec; 48(3):153-8. PubMed ID: 9449013 [TBL] [Abstract][Full Text] [Related]
20. Current challenges for the creation of effective vaccines against drugs of abuse. Moreno AY; Janda KD Expert Rev Vaccines; 2011 Dec; 10(12):1637-9. PubMed ID: 22085165 [No Abstract] [Full Text] [Related] [Next] [New Search]